In addition, we verified that overexpression of YOD1 could restrain the proliferation and invasion abilities of HNSCC cells by regulating the TRIM33-mediated ERK/β-catenin pathway. This evidence concerns the gene YOD1 and head and neck squamous cell carcinoma.